XBP1 is frequently upregulated in MM cells and serves as a pro-survival factor that controls immunoglobulin production and inhibits apoptosis through activation of nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) signaling pathways. Here, NFKB1 is linked to Miyoshi myopathy.